A detailed history of Ballentine Partners, LLC transactions in Alphatec Holdings, Inc. stock. As of the latest transaction made, Ballentine Partners, LLC holds 12,940 shares of ATEC stock, worth $138,975. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,940
Previous 13,009 0.53%
Holding current value
$138,975
Previous $131,000 9.16%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 15, 2025

SELL
$9.43 - $13.03 $650 - $899
-69 Reduced 0.53%
12,940 $143,000
Q1 2025

May 01, 2025

SELL
$9.06 - $12.53 $770 - $1,065
-85 Reduced 0.65%
13,009 $131,000
Q4 2024

Jan 16, 2025

BUY
$4.98 - $10.48 $65,208 - $137,225
13,094 New
13,094 $120,000

Others Institutions Holding ATEC

About Alphatec Holdings, Inc.


  • Ticker ATEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 104,656,000
  • Market Cap $1.12B
  • Description
  • Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The company offers SafeOp Neural InformatiX System, an Alpha InformatiX product platform designed to reduce the risk of intraoperative nerve injury; Sigma transforaminal lumbar interbody fusion pedic...
More about ATEC
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.